Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles

Circulation Journal

Volumn 70, Issue 11, 2006, Pages 1407-1414

  Yamazaki, Keisuke ^a   Terada, Hajime ^a   Satoh, Hiroshi ^a   Naito, Kensuke ^a   Takeshita, Akihiro ^a   Uehara, Akihiko ^a   Katoh, Hideki ^a   Ohnishi, Kazunori ^a   Hayashi, Hideharu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Action potential; Arsenic; QT interval; Triggered activity; Ventricular arrhythmias

Indexed keywords

ARSENIC TRIOXIDE;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; GUINEA PIG; HEART CONTRACTION; HEART PAPILLARY MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MUSCLE EXCITATION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PROMYELOCYTIC LEUKEMIA; QT INTERVAL; REPOLARIZATION; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ARRHYTHMIA; ARSENICALS; BUTYLATED HYDROXYTOLUENE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; GUINEA PIGS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIPID PEROXIDATION; LONG QT SYNDROME; MYOCARDIAL CONTRACTION; OXIDES; PAPILLARY MUSCLES; POISONS; REACTIVE OXYGEN SPECIES; TETRODOTOXIN;

EID: 33750574770     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1407     Document Type: Article

References (27)

1. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339: 1341-1348.
2. Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 2000; 133: 881-885.
3. Unnikrishnan D, Dutcher JP, Varshneya N, Lucariello R, Api M, Garl S, et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 2001; 97: 1514-1516.
4. Little RE, Kay GN, Cavender JB, Epstein AE, Plumb VJ. Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol 1990; 13: 164-170.
5. Chiang CE, Luk HN, Wang TM, Ding PY. Prolongation of cardiac repolarization by arsenic trioxide. Blood 2002; 100: 2249-2252.
6. Drolet B, Simard C, Roden DM. Unusual effects of a QT-prolonging drugs, arsenic trioxide, on cardiac potassium currents. Circulation 2004; 109: 26-29.
7. Matsuura H, Shattock MJ. Membrane potential fluctuations and transient inward currents induced by reactive oxygen intermediates in isolated rabbit ventricular cells. Circ Res 1991; 68: 319-329.
8. Samikkannu T, Chen CH, Yih LH, Wang AS, Lin SY, Chen TC, et al. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem Res Toxicol 2003; 16: 409-414.
9. Szinicz L, Forth W. Effect of As2O3 on gluconeogenesis. Arch Toxicol 1988; 61: 444-449.
10. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, et al. Use of arsenic trioxide in the treatment of acute promyelocytic leukemia. Blood 1997; 89: 3354-3360.
11. Wu MH, Lin CJ, Chen CL, Su MJ, Sun SS, Cheng AL. Direct cardiac effects of As2O3 in rabbits: Evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration. Toxicol Appl Pharmacol 2003; 189: 214-220.
12. Ramos O, Carrizales L, Yanez L, Mejia J, Batres L, Ortiz D, et al. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ Health Perspect 1995; 103: 85-88.
13. Wassmann S, Nickenig G, Bohm M. Long QT syndrome and torsade de pointes in a patient receiving fluconazole. Ann Intern Med 1999; 131: 797.
14. Antzelevitch C. T peak-T end interval as an index of transmural dispersion of repolarization. Eur J Clin Invest 2001; 31: 555-557.
15. Yan GX, Antzelvitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998; 98: 1928-1936.
16. Golub MS, Macintosh MS, Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: Animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1998; 1: 199-241.
17. Viskin S. Long QT syndrome and torsade de pointes. Lancet 1999; 354: 1625-1633.
18. Jing BY, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induced acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999; 94: 2102-2111.
19. Cerbai E, Ambrosio G, Porciatti F, Chiariello M, Giotti A, Mugelli A. Cellular electrophysiological basis for oxygen radical-induced arrhythmias. Circulation 1991; 84: 1773-1782.
20. Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ Res 1995; 76: 293-304.
21. Nakaya H, Tohse N, Kanno M. Electrophysiological derangements induced by lipid peroxidation in cardiac tissue. Am J Physiol 1987; 253: H1089-H1097.
22. Shen ZY, Shen WY, Chen MH, Shen J, Cai WJ, Zeng Y. Mitochondria, calcium and nitric oxide in the apoptotic pathway of esophageal carcinoma cells induced by As2O3. Int J Mol Med 2002; 9: 385-390.
23. Kaneko M, Matsumoto Y, Hayashi H, Kobayashi A, Yamazaki N. Oxygen free radicals and calcium homeostasis in the heart. Mol Cell Biochem 1994; 139: 91-100.
24. 2+ concentration of guinea pig heart. Cardiovasc Res 1989; 23: 767-773.
25. Beresewicz A, Horackova M. Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: Possible ionic mechanisms. J Mol Cell Cardiol 1991; 23: 899-918.
26. Bers D. Excitation-contraction coupling and cardiac contractile force: Dordrecht, Netherlands: Kluwer Academic Publishers; 2001.
27. Shimizu W, Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT condition. Circulation 1999; 99: 1499-1507.